Agios Pharmaceuticals ROA 2012-2019 | AGIO

Current and historical return on assets (ROA) values for Agios Pharmaceuticals (AGIO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Agios Pharmaceuticals ROA for the three months ending June 30, 2019 was -45.90%.
Agios Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $-0.39B $0.78B -45.98%
2019-03-31 $-0.35B $0.82B -38.70%
2018-12-31 $-0.35B $0.86B -36.29%
2018-09-30 $-0.34B $0.93B -38.31%
2018-06-30 $-0.33B $1.00B -38.93%
2018-03-31 $-0.34B $1.04B -43.71%
2017-12-31 $-0.31B $0.61B -47.96%
2017-09-30 $-0.28B $0.69B -42.99%
2017-06-30 $-0.27B $0.76B -41.09%
2017-03-31 $-0.24B $0.56B -40.07%
2016-12-31 $-0.20B $0.62B -35.28%
2016-09-30 $-0.18B $0.67B -35.78%
2016-06-30 $-0.16B $0.56B -35.11%
2016-03-31 $-0.14B $0.40B -31.28%
2015-12-31 $-0.12B $0.42B -25.98%
2015-09-30 $-0.10B $0.45B -22.02%
2015-06-30 $-0.06B $0.47B -14.04%
2015-03-31 $-0.05B $0.47B -12.20%
2014-12-31 $-0.05B $0.49B -17.43%
2014-09-30 $-0.04B $0.27B -16.43%
2014-06-30 $-0.05B $0.27B -24.71%
2014-03-31 $-0.05B $0.18B -25.81%
2013-12-31 $-0.04B $0.20B -32.39%
2013-06-30 $-0.02B $0.11B -79.28%
2013-03-31 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.491B $0.094B
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.840B 28.17
Medtronic (MDT) Ireland $137.817B 19.69
Stryker (SYK) United States $81.180B 28.07
Boston Scientific (BSX) United States $58.714B 28.48
Baxter (BAX) United States $44.403B 26.93
EssilorLuxottica Societe Anonyme (ESLOY) France $30.829B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.130B 18.00
Coloplast (CLPBY) Denmark $26.395B 42.14
Lonza Group Ag (LZAGY) Switzerland $26.038B 0.00
Terumo (TRUMY) Japan $23.788B 27.35
Smith & Nephew SNATS (SNN) United Kingdom $20.267B 0.00
ResMed (RMD) United States $19.315B 36.83
Sunny Optical Technology (SNPTF) China $13.689B 0.00
Bio-Rad Laboratories (BIO) United States $9.759B 52.32
Canopy Growth (CGC) Canada $9.745B 0.00
Insulet (PODD) United States $9.055B 536.57
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Haemonetics (HAE) United States $7.033B 53.07
Hill-Rom Holdings (HRC) United States $7.032B 20.97
Perrigo (PRGO) Ireland $6.283B 11.57
Aurora Cannabis (ACB) Canada $6.094B 59.90
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.651B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.710B 61.70
ICU Medical (ICUI) United States $3.430B 22.25
NuVasive (NUVA) United States $3.316B 26.44
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.552B 25.34
National Vision Holdings (EYE) United States $2.177B 46.98
Cardiovascular Systems (CSII) United States $1.682B 0.00
Aphria (APHA) $1.551B 0.00
Phibro Animal Health (PAHC) United States $1.263B 18.92
AtriCure (ATRC) United States $1.060B 0.00
VAREX IMAGING (VREX) United States $1.018B 23.45
NanoString Technologies (NSTG) United States $0.977B 0.00
Omeros (OMER) United States $0.967B 0.00
PetIQ (PETQ) United States $0.908B 21.44
Lantheus Holdings (LNTH) United States $0.897B 23.57
Eagle Pharmaceuticals (EGRX) United States $0.794B 20.23
Cerus (CERS) United States $0.769B 0.00
MacroGenics (MGNX) United States $0.737B 0.00
Quanterix (QTRX) United States $0.702B 0.00
TG Therapeutics (TGTX) United States $0.648B 0.00
LeMaitre Vascular (LMAT) United States $0.626B 37.08
Surmodics (SRDX) United States $0.601B 114.26
OraSure Technologies (OSUR) United States $0.446B 20.63
Meridian Bioscience (VIVO) United States $0.432B 13.48
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.423B 0.00
BioLife Solutions (BLFS) United States $0.376B 123.63
United Health Products (UEEC) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.349B 25.56
Zynex (ZYXI) United States $0.345B 36.62
Owens & Minor (OMI) United States $0.306B 9.17
Bovie Medical (APYX) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Cytosorbents (CTSO) United States $0.155B 0.00
Chimerix (CMRX) United States $0.153B 0.00
Fonar (FONR) United States $0.152B 8.01
Rockwell Medical (RMTI) United States $0.152B 0.00
Female Health (VERU) United States $0.123B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.087B 20.65
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Surface Oncology (SURF) United States $0.055B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.17
Senestech (SNES) United States $0.039B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00